Science
Mechanism of Action
This extract utilizes a high concentration of iridoid glycosides, specifically barlerin and acetylbarlerin, to downregulate pro-inflammatory pathways by inhibiting COX-2 enzymes. Its rich phenolic and flavonoid profile neutralizes oxidative stress through radical scavenging, while its antimicrobial properties disrupt the lipid membranes of common pathogens like S. aureus and C. albicans without compromising skin barrier integrity.
Research
Clinical Evidence
Medium confidence5%
Key findings
- 01 Demonstrated significant antimicrobial activity against B. subtilis and S. enterica at concentrations starting from 12.5 mg/mL.
- 02 A 5% topical application showed measurable acceleration in re-epithelialization and wound closure in traditional clinical usage.
- 03 In vivo models confirmed systemic safety at 100 mg/kg alongside potent anti-inflammatory and antioxidant responses.
Transparency
Dusting Analysis
Because it is often marketed for its exotic 'Vajradanti' heritage, brands frequently include it at negligible levels (<0.1%) for label claims. However, clinical data suggests that a concentration of 1-5% is necessary to achieve meaningful antimicrobial and healing benefits.
The Formula
Formulation
Stability
Heat-sensitive; must be incorporated during the cool-down phase below 40°C to maintain the integrity of its iridoid glycosides. Most stable in water-based or hydro-glycolic systems.
Synergies
- Niacinamide
- Glycerin
- Hyaluronic Acid
Conflicts
- Strong oxidizing agents
- Highly alkaline formulations (pH > 8.0)
Safety
Safety Profile
Recognized by the EU CosIng and FDA (UNII Y9V25E14ZR). While no formal CIR monograph exists, it has a long history of safe use in Ayurvedic oral and topical applications with no reported acute toxicity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An underutilized botanical powerhouse that offers scientifically backed soothing and antimicrobial properties for compromised or reactive skin.
Related
Similar Ingredients
Finding similar ingredients…